• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer?ECOG-ACRIN E2108试验结果：这是转移性乳腺癌原发手术的终结吗？
Eur J Breast Health. 2020 Dec 24;17(1):84-85. doi: 10.4274/ejbh.2020.6222. eCollection 2021 Jan.
2
Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 Trial.新发转移性乳腺癌患者原发肿瘤完整的局部区域治疗；ECOG-ACRIN 2108试验的评论与关注
Eur J Breast Health. 2020 Jun 8;16(3):158-159. doi: 10.5152/ejbh.2020.080620. eCollection 2020 Jul.
3
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805).Eribulin 治疗转移性去势抵抗性前列腺癌患者的 II 期临床试验：ECOG-ACRIN 癌症研究组（E5805）的一项试验。
Am J Clin Oncol. 2019 Apr;42(4):375-381. doi: 10.1097/COC.0000000000000526.
4
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104).一项关于伏立诺他（SAHA）联合曲妥珠单抗（赫赛汀）治疗晚期转移性和/或局部胸壁复发的HER2扩增乳腺癌患者的I/II期研究：东部肿瘤协作组（ECOG）-美国放射肿瘤学会（ACRIN）癌症研究组（E1104）的一项试验
Breast Cancer Res Treat. 2017 Sep;165(2):375-382. doi: 10.1007/s10549-017-4310-9. Epub 2017 Jun 16.
5
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.局部晚期直肠癌患者术前放疗联合卡培他滨、奥沙利铂和贝伐单抗，随后手术及术后使用5-氟尿嘧啶、亚叶酸钙、奥沙利铂（FOLFOX）和贝伐单抗的II期试验：5年临床结果 ECOG-ACRIN癌症研究组E3204
Oncologist. 2015 Jun;20(6):615-6. doi: 10.1634/theoncologist.2015-0106. Epub 2015 Apr 29.
6
[Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial].导管原位癌辅助放疗的省略：ECOG-ACRIN E5194试验的12年结果
Strahlenther Onkol. 2016 May;192(5):349-51. doi: 10.1007/s00066-016-0966-z.
7
Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer.寡转移乳腺癌患者单纯放疗治疗转移性脊髓压迫后的结局
Anticancer Res. 2018 Dec;38(12):6897-6903. doi: 10.21873/anticanres.13066.
8
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.E1308：诱导化疗后降低剂量放疗联合西妥昔单抗每周治疗人乳头瘤病毒相关可切除口咽鳞状细胞癌患者的II期试验 - ECOG-ACRIN癌症研究组
J Clin Oncol. 2017 Feb 10;35(5):490-497. doi: 10.1200/JCO.2016.68.3300. Epub 2016 Dec 28.
9
Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial.转移性去势抵抗性前列腺癌中每周紫杉醇联合雌莫司汀的 2 期研究：ECOG-ACRIN 癌症研究组（E1898）试验。
Clin Genitourin Cancer. 2018 Apr;16(2):e315-e322. doi: 10.1016/j.clgc.2017.10.001. Epub 2017 Oct 16.
10
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?新发转移性乳腺癌原发肿瘤的手术治疗：做还是不做？
Eur J Surg Oncol. 2015 Oct;41(10):1288-92. doi: 10.1016/j.ejso.2015.07.013. Epub 2015 Jul 29.

本文引用的文献

1
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.随机对照试验比较初诊 IV 期乳腺癌中肿瘤切除术与无手术治疗的疗效：MF07-01 方案。
Ann Surg Oncol. 2018 Oct;25(11):3141-3149. doi: 10.1245/s10434-018-6494-6. Epub 2018 May 17.
2
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.局部区域治疗与转移性乳腺癌中肿瘤原发灶不治疗的比较：一项开放标签随机对照试验。
Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9.

Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer?

作者信息

Luz Paulo

机构信息

Department of Medical Oncology, Centro Hospitalar Universitário do Algarve; CBIOS - Research Center for Biosciences and Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Faro, Portugal.

出版信息

Eur J Breast Health. 2020 Dec 24;17(1):84-85. doi: 10.4274/ejbh.2020.6222. eCollection 2021 Jan.

DOI:10.4274/ejbh.2020.6222
PMID:33796836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8006780/
Abstract
摘要